Chris Shaw
Aluminium
[2012 Nov] UBC researchers advocate HPV vaccine scrutiny A human papillomavirus (HPV) vaccine may trigger fatal autoimmune or neurological events in some cases, two UBC researchers say. Their findings come as public-health authorities, who maintain that the shots are safe, are urging young women to get vaccinated to prevent cervical cancer.
[vid] Vaccines Are Perfectly Safe, Right?
Do Aluminum Vaccine Adjuvants Contribute to Rising Prevalence of Autism?
[2012 March] UPDATE FROM DR. SHAW – ACETAMINOPHEN AND AUTISM CONNECTION “It appears that the marked increase in the rate of autism throughout much of the world may be largely mediated by the marked increase in the use of acetaminophen in genetically and/or metabolically susceptible children and perhaps the use of acetaminophen by pregnant women.”
[2009 Nov] What’s in your H1N1 flu vaccine? Shaw turned to the 24-page product-information leaflet on the vaccine released by drug giant GlaxoSmithKline. Health Canada used this document in approving the shot. The leaflet leaves Shaw cold. “You couldn’t turn this in as a master’s thesis anywhere I know of and get a passing grade,” he said, calling the leaflet a “shocking document”. Shaw said the material lacks basic information. For example, there is no safety data at all for several groups of people—pregnant women, people aged over 60, kids aged 10 to 17, and children under three. For kids three to nine years old, there is only “very limited” data. “Where is the safety data that the government used to license the vaccine?” Shaw asked.
Do aluminum vaccine
adjuvants contribute to the rising prevalence of autism?
Tomljenovic L, Shaw CA.
J Inorg Biochem. 2011 Nov;105(11):1489-99. Epub 2011 Aug 23.
pdf here
Autism spectrum disorders (ASD) are serious multisystem developmental disorders
and an urgent global public health concern. Dysfunctional immunity and impaired
brain function are core deficits in ASD. Aluminum (Al), the most commonly used
vaccine adjuvant, is a demonstrated neurotoxin and a strong immune stimulator.
Hence, adjuvant Al has the potential to induce neuroimmune disorders. When
assessing adjuvant toxicity in children, two key points ought to be considered:
(i) children should not be viewed as "small adults" as their unique physiology
makes them much more vulnerable to toxic insults; and (ii) if exposure to Al
from only few vaccines can lead to cognitive impairment and autoimmunity in
adults, is it unreasonable to question whether the current pediatric schedules,
often containing 18 Al adjuvanted vaccines, are safe for children? By applying
Hill's criteria for establishing causality between exposure and outcome we
investigated whether exposure to Al from vaccines could be contributing to the
rise in ASD prevalence in the Western world. Our results show that: (i) children
from countries with the highest ASD prevalence appear to have the highest
exposure to Al from vaccines; (ii) the increase in exposure to Al adjuvants
significantly correlates with the increase in ASD prevalence in the United
States observed over the last two decades (Pearson r=0.92, p<0.0001); and (iii)
a significant correlation exists between the amounts of Al administered to
preschool children and the current prevalence of ASD in seven Western countries,
particularly at 3-4 months of age (Pearson r=0.89-0.94, p=0.0018-0.0248). The
application of the Hill's criteria to these data indicates that the correlation
between Al in vaccines and ASD may be causal. Because children represent a
fraction of the population most at risk for complications following exposure to
Al, a more rigorous evaluation of Al adjuvant safety seems warranted.
[pdf 2007]
Michael S. Petrik, et al. Aluminum Adjuvant
Linked to Gulf War Illness Induces Motor Neuron Death
in Mice. NeuroMolecular Medicine
2007.
[pdf 2006/7]
ALUMINUM ADJUVANT LINKED TO GULF WAR SYNDROME INDUCES
MOTOR NEURON DEATH IN MICE M.S. Petrik1,2,
M.C. Wong1,2, R.C. Tabata1, R.F. Garry5 and C.A. Shaw1,3,4
[Media 3/2006
Aluminium adjuvant] Vaccines show sinister side
Vancouver neuroscientist Chris Shaw shows a link between the aluminum hydroxide
used in vaccines, and symptoms associated with Parkinson’s, amyotrophic lateral
sclerosis (ALS, or Lou Gehrig’s disease), and Alzheimer’s.....“This
is suspicious,” he told the Georgia Straight in a phone interview from his lab
near Heather Street and West 12th Avenue. “Either this [link] is known by
industry and it was never made public, or industry was never made to do these
studies by Health Canada. I’m not sure which is scarier.”
Similar adjuvants are used in the following vaccines, according to Shaw’s
paper: hepatitis A and B, and the Pentacel cocktail, which vaccinates against
diphtheria, pertussis, tetanus, polio, and a type of meningitis....“No
one in my lab wants to get vaccinated,” he said. “This totally creeped us out.
We weren’t out there to poke holes in vaccines. But all of a sudden, oh my
God—we’ve got neuron death!”Another important factor with regard to mercury on the mind, which officials
at the CDC, FDA and the professors in the IOM do not consider, is
synergistic toxicity - mercury's enhanced effect when other poisons are
present. A small dose of mercury that kills 1 in 100 rats and a dose of
aluminum that will kill 1 in 100 rats, when combined have a striking
effect: all the rats die. Doses of mercury that have a
1 percent mortality will have a 100 percent mortality
rate if some aluminum is there. Vaccines contain
aluminum.
[pdf 2006/7]
ALUMINUM ADJUVANT LINKED TO GULF WAR SYNDROME INDUCES
MOTOR NEURON DEATH IN MICE M.S. Petrik1,2,
M.C. Wong1,2, R.C. Tabata1, R.F. Garry5 and C.A. Shaw1,3,4
ABSTRACT: Gulf War Syndrome (GWS) affects a high percentage of
veterans of the 1991 conflict, but its origins
remain unknown. One neurological complication of GWS is an increased
incidence of amyotrophic lateral sclerosis (ALS). While many
environmental factors have been linked to GWS, the
role of the anthrax vaccine administered to deployed
troops has come under increasing scrutiny. Among the vaccine’s
potentially toxic components are the adjuvant
aluminum hydroxide and squalene. To examine whether
these materials might contribute to neurologic toxicity, we injected
young male colony CD-1 mice with these adjuvants
at doses equivalent to those given to service personnel.
Mice were subjected to a battery of motor and cognitive behavioral
tests over a six month period. Following
sacrifice, CNS tissue was examined using immunohistochemistry for
evidence of neural death. Behavioral testing showed both motor and
cognitive functions were impacted by the tested
adjuvants to differing degrees. Apoptotic neurons were
identified in lumbar spinal cord and motor cortex in the groups
receiving the adjuvants. Aluminum injected
animals also showed a significant increase of astrocytes in the lumbar
spinal cord. Our findings suggest a possible role for either or both
compounds in some neurological features associated
with GWS.